Rchr
J-GLOBAL ID：201801006901929552
Update date: Apr. 12, 2024
Mishiro Kenji
ミシロ ケンジ | Mishiro Kenji
Affiliation and department：
Job title：
Assistant Professor (Tenure Track)
Homepage URL (1)：
https://ridb.kanazawa-u.ac.jp/public/detail.php?id=4487
Research field (1)：
Pharmaceuticals - chemistry and drug development
Research keywords (6)：
Radiopharmaceutical
, Chirality
, Organocatalyst
, Photochemistry
, Medicinal Chemistry
, Organic Chemistry
Research theme for competitive and other funds (15)：
- 2023 - 2030 Life Science Research Based on Acidic Functional Group Modification in Water
- 2022 - 2025 development of photochemical reactions using cyclic carbonyl compoundsl
- 2021 - 2025 局所療法を融合した発展型ラジオセラノスティクス用プローブ開発研究
- 2021 - 2024 カルボカチオンの制御に関する方法論の確立と求核置換反応への展開
- 2021 - 2023 Development of a highly selective bioconjugation method using protein interactions
- 2020 - 2022 Photochemical Transformation of Carboxy Groups using Cyclopropenones
- 2018 - 2021 Establishment of comprehensive cancer diagnosis and therapy using radio halogen
- 2017 - 2021 Development of novel reagents taking the advantage of the electron deficient nitrogen-containing heterocycles
- 2020 - 2021 環状ケトン化合物を活用する光駆動型反応に関する研究
- 2020 - 2021 Development of Cyclopropenone Derivatives as Photoreactive Groups and Bioactive Compounds
- 2019 - 2020 Medicinal Chemistry Research Using Novel Strained Molecules
- 2018 - 2020 Development of a novel bioactive ionic molecules having strained structures
- 2018 - 2020 Development of phototriggered reactions using strained molecules
- 2016 - 2018 Phototriggered generation of active species and its application to a biomolecule labeling
- 2010 - 2012 基質認識型触媒を用いる糖類の位置選択的官能基化
Show all
Papers (52)：
-
Hiroaki Echigo, Masayuki Munekane, Takeshi Fuchigami, Kohshin Washiyama, Kenji Mishiro, Hiroshi Wakabayashi, Kazuhiro Takahashi, Seigo Kinuya, Kazuma Ogawa. Optimizing the pharmacokinetics of an 211At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor. European journal of nuclear medicine and molecular imaging. 2024
-
Kazuma Ogawa, Kota Nishizawa, Kenji Mishiro, Nurmaya Effendi, Takeshi Fuchigami, Masayuki Munekane, Hiroshi Wakabayashi, Seigo Kinuya. Synthesis and Evaluation of Radiogallium Labeled Bone-Imaging Probes Using Oligo-γ-Carboxy Glutamic Acid Peptides as Carriers to Bone. Molecular pharmaceutics. 2024
-
Kenji Mishiro, Aiko Sesumi, Takanori Fujii, Taniyuki Furuyama, Munetaka Kunishima. Phototriggered Butenolide Formation from a Cyclobutenedione and an Acidic Nucleophile. Organic letters. 2024. 26. 1. 380-384
-
Muammar Fawwaz, Kenji Mishiro, Arwansyah Arwansyah, Ryuichi Nishii, Kazuma Ogawa. Synthesis and initial in vitro evaluation of olmutinib derivatives as prospective imaging probe for non-small cell lung cancer. BioImpacts : BI. 2024. 14. 1. 27774-27774
-
Saki Horie, Kenji Mishiro, Mio Nishino, Inori Domae, Mitsuo Wakasugi, Tsukasa Matsunaga, Munetaka Kunishima. Epitope-Based Specific Antibody Modifications. Bioconjugate chemistry. 2023. 34. 11. 2022-2033
ｍore...
MISC (4)：
Patents (2)：
-
代替抗癌剤の治療効果予測剤
-
オリゴペプチド誘導体およびそれを用いた医薬
Education (2)：
- 2008 - 2013 Kyoto University Graduate School of Pharmaceutical Science Pharmaceutical Science
- 2004 - 2008 Kyoto University School of Pharmacy Total Pharmaceutical Science
Professional career (1)：
- PhD (Pharmaceutical Science) (Kyoto University)
Work history (4)：
- 2021/01 - 現在 Kanazawa University Institute for Frontier Science Initiative Associate Professor
- 2016/01 - 2021/01 Kanazawa University Institute for Frontier Science Initiative Assistant Professor (Tenure Track)
- 2013/08 - 2016/01 Columbia University Department of Chemistry Postdoctoral Research Fellow
- 2012/01 - 2012/03 University of Edinburgh School of Chemistry Visiting Reseacher
Association Membership(s) (3)：
American Chemical Society
, THE SOCIETY OF SYNTHETIC ORGANIC CHEMISTRY, JAPAN
, THE PHARMACEUTICAL SOCIETY OF JAPAN
